ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Dec 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
January 2026
Nuclear Technology
December 2025
Fusion Science and Technology
November 2025
Latest News
Seconds Matter: Rethinking Nuclear Facility Security for the Modern Threat Landscape
In today’s rapidly evolving threat environment, nuclear facilities must prioritize speed and precision in their security responses—because in critical moments, every second counts. An early warning system serves as a vital layer of defense, enabling real-time detection of potential intrusions or anomalies before they escalate into full-blown incidents. By providing immediate alerts and actionable intelligence, these systems empower security personnel to respond decisively, minimizing risk to infrastructure, personnel, and the public. The ability to anticipate and intercept threats at the earliest possible stage not only enhances operational resilience but also reinforces public trust in the safety of nuclear operations. Investing in such proactive technologies is no longer optional—it’s essential for modern nuclear security.
2024 ANS Annual Conference
Ben Goodrich has spent his career in nuclear-adjacent technology development. As a Director, Ben leads a farrago of business functions including Strategy, Business Development, and Sales within TerraPower Isotopes, an emerging global supplier of actinium-225 used with radioligand therapy for cancer treatments. His expertise includes commercialization, deal structuring and negotiation, financial modeling, clinical trials forecasting, and isotope demand planning.
Ben has enjoyed over a decade of leading technical projects and turning ideas into reality at TerraPower. Prior to TerraPower, Ben worked at Idaho National Laboratory within the Technology Transfer and Commercialization Office.
Ben earned an MBA from Idaho State University and an undergrad from BYU-Idaho. He holds PMP, CVA, and CLP credentials and has multiple patents on hydrocarbon fractionation and liquefaction using super-critical CO2.
Ben currently lives in Northwest Montana with his wife and four children. In his spare time, Ben leads outdoor adventure trips with teenagers and does regular hands-on ‘research’ to find the best trout flies.
Last modified May 30, 2024, 9:12am PDT
